Good Clinical Practice (GCP)
Full course · Clinical Research Foundations
Free Lesson Preview
This lesson is part of a complete GCP track — 2 courses, quizzes, a final exam, and a free verifiable credential. The optional $29 PDF certificate is recognized by 18+ trial sponsors.
Start learning for freeAlready enrolled? Sign in
How potential participants discover clinical trials, navigate the screening process, and move from initial interest to enrollment.
What you will learn5 objectives
By the end of this lesson, you will be able to:
Clinical trials do not announce themselves. Someone must bridge the gap between a study that needs participants and the people who might benefit from participating. This happens through multiple channels, each reaching different populations in different ways.
The most common path to clinical trial participation begins with a physician, nurse practitioner, or other healthcare provider. Providers who stay current with research in their specialty often know about trials that might help their patients.
This pathway has significant advantages. The provider already understands the patient's medical history, current treatments, and overall health status. They can make an initial assessment of whether a trial might be appropriate before suggesting it. And the conversation happens in the context of an established relationship built on trust.
However, not all providers are equally aware of available trials, and some may hesitate to suggest research participation for various reasons. As a clinical research professional, you can help by encouraging referring physicians to discuss trial options with their patients. Providing educational materials that physicians can share during appointments helps open these conversations.
Progress saves itself — finish reading and this lesson completes
The largest repository of clinical trial information in the world is ClinicalTrials.gov, a database maintained by the U.S. National Library of Medicine. As of 2024, it lists over 450,000 studies from more than 220 countries and territories. Every trial conducted under FDA oversight must be registered, and most international trials appear as well.
ClinicalTrials.gov allows anyone to search for trials by condition, treatment type, location, and other criteria. Each listing includes the trial's purpose, eligibility requirements, locations, and contact information. The database is free and publicly accessible.
Other registries serve specific regions or purposes. The European Union Clinical Trials Register covers trials in EU member states. The World Health Organization maintains an International Clinical Trials Registry Platform that aggregates information from multiple national registries. Disease-specific registries exist for conditions like cancer, rare diseases, and infectious diseases.
Organizations focused on specific diseases often maintain information about clinical trials relevant to their communities. The Arthritis Foundation, the American Cancer Society, the Cystic Fibrosis Foundation, and hundreds of similar organizations help connect patients with research opportunities.
These organizations bring expertise in their specific conditions. They can explain complex medical concepts in accessible language, provide emotional support alongside practical information, and advocate for patient interests in the research process. For someone newly diagnosed with a serious condition, an advocacy organization may be the first place they turn for guidance.
Sponsors and research sites frequently advertise for clinical trial participants. You may see these advertisements in physician waiting rooms, on community bulletin boards, in local newspapers, or on public transportation. They typically describe the condition being studied, highlight potential benefits of participation, and provide contact information.
Such advertising is regulated. The FDA and Institutional Review Boards require that recruitment materials be reviewed to ensure they are not misleading. Advertisements cannot promise that a treatment will work, cannot overstate the benefits of participation, and cannot minimize the risks. Still, the nature of advertising is to attract interest, so potential participants should view recruitment materials as an invitation to learn more, not as a complete picture.
Research sponsors increasingly use digital channels to find participants. Targeted advertisements on social media platforms can reach people who have searched for information about specific conditions or who match demographic profiles relevant to a study. Some companies specialize in digital patient recruitment, using sophisticated algorithms to identify potential participants.
Online communities and support groups for specific conditions often share information about clinical trials. A patient in a Facebook group for multiple sclerosis might learn about a trial from another member's post. These peer-to-peer channels can reach people who might not encounter trial information through traditional medical channels.
